Form 4 for MGNX MACROGENICS INC
Accepted 2023-12-21 00:00:00 ET · period of report 2023-12-20 · accession 0001125345-23-000131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-21 | 2023-12-20 | MGNX | Bonvini Ezio | SVP, CSO, Research | S - Sale | $10.08 | -18.9K | 101.3K | -16% | -$190.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-20 | S | D | 18,880 | $10.08 | 101,300 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023 |